Blue Water Acquisition III Unit. (BLUWU) vs Silexion Therapeutics (SLXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLUWU | SLXN |
|---|---|---|
| Share price | $10.42 | $1.31 |
| Market cap | — | $850.88K |
| 1-day change | 0.00% | -12.67% |
| YTD return | -1.23% | — |
| EPS (TTM) | — | $-2,437.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $4.67M | $-11.91M |
| 52-week high | $12.85 | $777.12 |
| 52-week low | $0.00 | $1.26 |
| Distance from 52-week high | -18.91% | -99.83% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +281.68% |
| Average volume | 45 | 431.20K |
| Shares outstanding | — | 649.53K |
| Employees | — | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Blue Water Acquisition III Unit.
BLUWU stock →Blue Water Acquisition Corp. III does not have significant operations.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
BLUWU vs SLXN FAQ
Are Blue Water Acquisition III Unit. and Silexion Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.